AG001626

1218-35-5 | 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1)

Chemical structure of 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1), CAS 1218-35-5
AG001626
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1218-35-5
Catalog Number AG001626(AGN-PC-0PFRJI)
Chemical Name 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1)
EC Number 214-936-4
IUPAC Name 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride
InChI InChI=1S/C16H24N2.ClH/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15;/h8-9H,6-7,10H2,1-5H3,(H,17,18);1H
InChI Key YGWFCQYETHJKNX-UHFFFAOYSA-N
MDL Number MFCD00238707
Molecular Formula C16H25ClN2
Molecular Weight 280.8361
NSC Number 757378
SMILES CC1=C(C(C)=CC(C(C)(C)C)=C1)CC2=NCCN2.[H]Cl
UNII X5S84033NZ
Synonyms
2-(4'-tert-butyl-2',6'-dimethylphenylmethyl)imidazoline, Amidrin, Balkis, Chlorohist-LA, Decongest, espa-rhin, Gelonasal, Idasal, Idril N, Imidin, Nasan, Nasengel AL, NasenGel ratiopharm, Nasenspray AL, NasenSpray ratiopharm, Nasentropfen AL, NasenTropfen ratiopharm, Novorin, Otradrops, Otraspray, Otriven, Otrivin, Otrivin Mentol, Rapako, schnupfen endrine, Snup, stas, xylometazoline, xylometazoline hydrochloride, xylometazoline monohydrochloride, Xylometazoline hydrochloride, 1218-35-5, Xylometazoline HCl, 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride, Xylometazoline (hydrochloride), MFCD00238707, MLS000069695, UNII-X5S84033NZ, SMR000058526, DSSTox_CID_25223, DSSTox_RID_80760, DSSTox_GSID_45223, Xylometazoline hydrochloride, 98%, 2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride, 2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride, 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride, 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1), X5S84033NZ, Xylometazoline hydrochloride (USP), SR-01000000230, NCGC00016101-02, CAS-1218-35-5, stas hydrochloride, xylometazoline-hcl, otrivinhydrochloride, otrivinehydrochloride, Prestwick_574, AC1NQZZM, 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride, Opera_ID_1744, xylometazolin hydrochloride, Neo-Synephrine II (TN), SCHEMBL41837, MLS001076518, SPECTRUM1500614, CHEMBL1256400, DTXSID3045223, CTK4B2768, REGID_for_CID_5282386, YGWFCQYETHJKNX-UHFFFAOYSA-N, HMS1568N07, HMS1921K09, Pharmakon1600-01500614, Xylometazoline Hydrochloride ,(S), BCP22148, HY-B0475, Tox21_110305, Tox21_501269, ANW-41892, CCG-39900, NSC757378, s2576, AKOS015895456, Tox21_110305_1, AC-8301, AN-8175, API0006284, CS-2589, KS-5144, LP01269, NSC-757378, NCGC00016101-10, NCGC00094506-01, NCGC00094506-02, NCGC00094506-03, NCGC00094506-04, NCGC00094506-05, NCGC00261954-01, AK608063, H812, AB0013278, AB1009546, TR-003540, EU-0101269, FT-0603554, SW196748-3, D00757, K-1647, X 6000, Xylometazoline hydrochloride, analytical standard, 218X355, A804796, I06-0599, J-004686, SR-01000000230-2, SR-01000000230-7, 2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazolinmonohydrochloride, Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard, Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard, 2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1h-imidazol, Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard, Otrivine, Rhinactin, Olynth, Neo-Synephrine II, Otrivin hydrochloride, Otrivine hydrochloride, C16H25ClN2, C16H24N2.ClH, (R)-3-(Methylamino)pyrrolidine, C16-H24-N2.Cl-H, XYLOMETAZOLINEHYDROCHLORIDE, Xylometazoline hydrochloride [USP], EINECS 214-936-4, CID5282386, B2066, X0063, 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline monohydrochloride, 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride, Xylometazoline hydrochloride, 98%, an alpha-adrenoceptor agonist - 1G 1g, 2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-, MONOHYDROCHLORIDE, 1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-, monohydrochloride,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited